Literature DB >> 28954123

Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasis - Reply.

Priscila Miranda Diogo Mesquita1, Augusto Diogo2, Miguel Tanus Jorge3, Alceu Luiz Camargo Villela Berbert4, Sônia Antunes de Oliveira Mantese4, José Joaquim Rodrigues4.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28954123      PMCID: PMC5595621          DOI: 10.1590/abd1806-4841.20177256

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


× No keyword cloud information.
Dear editor, As mentioned in the article in question, the selected control group had 21 volunteers without skin diseases and without gastrointestinal symptoms.[1] This group was composed of people with similar socioeconomic status as the patients and who were accompanying those patients during the visits or who had been attended at a neighboring outpatient clinic. We agree that our control group had a small number of participants because of the difficulty in getting healthy people willing to undergo blood collection without any material gain in return. The methods for the diagnosis of Helicobacter pylori are divided into invasive and non-invasive. In our study, we used the Elisa serological test, a noninvasive method ideal for epidemiological studies, based on the identification of H. pylori-specific IgG antibodies in the patient's serum. However, the has some restrictions. It only detects host exposure to the bacterium, without diagnosing active infection (true infection) (Krogfelt et al., 2005).[2] We chose this method due to its reduced cost and the low complexity of accomplishment in relation to other diagnostic methods. We believe that the patient's contact with H. pylori alone is sufficient to trigger the immunological cascade implicated in the pathogenesis of psoriasis. As in our study, Qayoom and Ahmad detected H. pylori antibodies in 40% of psoriasis patients and 10% of control subjects (healthy subjects without gastrointestinal complaints) and concluded that H. pylori plays a causal role in the pathogenesis of psoriasis.[3] Similarly, Fathy et al. compared 20 plaque psoriasis patients with 20 healthy volunteers, matched for age and gender, and tested them for H. pilory antibodies using the Elisa test. The mean prevalence of seropositivity in psoriatic patients was significantly higher when compared to controls. Also, the high values ​​correlated with the severity of the disease. They concluded that there is a link between H. pylori and psoriasis and that the bacterium may also influence the pathogenesis of the disease.[4]
  3 in total

Review 1.  Diagnosis of Helicobacter pylori Infection.

Authors:  Karen A Krogfelt; Philippe Lehours; Francis Mégraud
Journal:  Helicobacter       Date:  2005       Impact factor: 5.753

2.  Psoriasis and Helicobacter pylori.

Authors:  S Qayoom; Q M Ahmad
Journal:  Indian J Dermatol Venereol Leprol       Date:  2003 Mar-Apr       Impact factor: 2.545

3.  Relationship of Helicobacter pylori seroprevalence with the occurrence and severity of psoriasis.

Authors:  Priscila Miranda Diogo Mesquita; Augusto Diogo; Miguel Tanus Jorge; Alceu Luiz Camargo Villela Berbert; Sônia Antunes de Oliveira Mantese; José Joaquim Rodrigues
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

  3 in total
  1 in total

Review 1.  Helicobacter pylori and extragastric diseases: A review.

Authors:  Antonietta Gerarda Gravina; Rocco Maurizio Zagari; Cristiana De Musis; Lorenzo Romano; Carmelina Loguercio; Marco Romano
Journal:  World J Gastroenterol       Date:  2018-08-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.